New research shows major sleep disturbances overlooked in management of patients with Parkinson's disease

nly gives a general indication of daytime sleepiness and does not address the nature of the sleep disruption common in patients with PD.

Dr Chaudhuri advised, "Sleep disturbance, insomnia and its implications such as excessive daytime sleepiness are a major cause of morbidity and impaired quality of life for patients with PD. We need to be aware of the impact of sleep disturbance on PD patients' lives, and should treat them with therapies shown to improve this problem".

He presented results in a group of patients who used the PDSS. The PDSS measures the level of sleep disturbance by asking patients to assess the severity of 15 commonly reported symptoms associated with sleep disturbance in PD, with an easy-to-use visual scale. The PDSS has demonstrated the ability to objectively quantify the effects of drug therapy in the management of sleep symptoms.

Results from 62 patients (mean age 65.9 years), diagnosed with PD an average of 6.1 years, showed that the mean total PDSS score was 92.0 out of a maximum score of 150 (range 46-150, with a lower score indicating more sleep disturbance). A group of 16 patients in the study were tested before and after treatment with cabergoline, given for a mean period of eight months. Dr Chaudhuri reported that the mean total PDSS for this subgroup increased from 76.3 before treatment, to 99.1 post-therapy.

Explaining the results Dr Chaudhuri said, "Cabergoline therapy achieved statistically significant improvements in patients' quality of sleep over six of the 15 key symptoms of sleep disturbance. There were improvements in the patients' subjective rating of their sleep quality and a reduction in nocturnal awakenings". He suggested, "These improvements are likely due to the very long half-life of cabergoline (more than 65 hours) which allows improved symptom and fluctuation control throughout the night as well as the day".

Actigraphy -- Improving the assessment of movement disorders in PD Professo

Contact: Roseann Ward

Page: 1 2 3 4

Related medicine news :

1. Public morally obliged to take part in scientific research, says leading ethicist
2. U of M researcher says Viagra may cause permanent vision loss in some men
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
5. RIT takes eye-tracking research to next level
6. UW research shows risk factors for relapse among health care professionals who abuse drugs
7. Protein that helps skin cancer spread identified by Stanford researchers
8. US life expectancy about to decline, researchers say
9. Ethical discussion should come before research
10. Philanthropist Paul F. Glenn launches labs for aging research at Harvard Medical School
11. Gene for age-related macular degeneration discovered by Yale researchers

Post Your Comments:

(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... West Pharmaceutical Services, Inc. (NYSE: ... drug administration, today announced that it will release third-quarter ... October 26, 2017, and will follow with a conference ... 9:00 a.m. Eastern Time. To participate on the call, ... ID is 94093362. ...
(Date:10/11/2017)... 2017  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today ... Las Piedras, Puerto Rico , where ... Following a comprehensive ... minor structural damage, temporary loss of power and minimal ... completed, manufacturing operations have resumed, and the company expects ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
Breaking Medicine Technology:
Cached News: